13F

Stock

Acrivon Therapeutics, Inc.

ACRV · held by 4 managers

Reported value

$249.9K

Holders

4

+0 new · −0 exited

Holders’ est. mark

$12.4K

Price effect on 1 books still in the name

Largest holder

$103.5K

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY57.2K$103.5KHeld
BLUEFIN CAPITAL MANAGEMENT, LLC42K$76.1KHeld
BARCLAYS PLC20K$36.1K$12.4KAdded$11.2K
BANK OF AMERICA CORP /DE/18.9K$34.2KHeld

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.